Document is current
Any future updates will be listed below
-
Authors
Pop, C. Florin
Veys, Isabelle
Moreau, Michel
Paesmans, Marianne
De Azambuja, Evandro
Larsimont, Denis
Liberale, Gabriel
-
Funding
Funding for this research was provided by:
Association Jules Bordet (Grant 2022-11)
Renew Pharmaceuticals Limited / Diagnostic Green (2023.06.01)
- License Information
-
More Information
Article History
Received: 26 January 2025
Accepted: 13 February 2026
First Online: 3 March 2026
Declarations
:
: The study will be conducted in accordance with the principles of the Declaration of Helsinki on Medical Research Involving Human Subjects Act and in accordance with International Good Clinical Practice guidelines. The study protocol has received medical-ethical approval by the Belgian Ethics Authority and by the Belgian Federal Agency for Medicines and Health Products under the number 3608/2023/12/2. Protocol version 1.1 was approved on December 21, 2023. Written consent is obtained from each participant before enrollment. Participants are aware of the purpose, the fact that they have no direct advantages, and the risks of the trial.
: Not applicable.
: The authors declare that they have no competing interests.
